Resources | NITAG RESOURCE CENTER

2023 ∙ Haute Autorité de Santé

Vaccination strategy against pneumococcal infections - Place of pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed) in adults

2023 ∙ Haute Autorité de Santé

Update of vaccination recommendations and obligations for students and professionals in the health and medico-social sectors and in close contact with young children 2/2

2023 ∙ Haute Autorité de Santé

Update of vaccination recommendations and obligations for students and professionals in the health and medico-social sectors and in close contact with young children 1/2

2023 ∙ Commission Technique des Vaccinations

Vaccination strategy against Covid-19: anticipation of vaccination campaigns in 2023

2022 ∙ Haute Autorité de Santé

Vaccination strategy against Covid-19: Place of the VLA2001 vaccine

2022 ∙ Haute Autorité de Santé

Vaccination strategy against Covid-19: Place of the VidPrevtyn Beta vaccine

2022 ∙ Haute Autorité de Santé

Booster vaccine strategy against Covid-19

2022 ∙ Haute Autorité de Santé

Vaccination strategy against Covid-19: Place of the Nuvaxovid vaccine in the booster strategy

2022 ∙ Haute Autorité de Santé

Vaccination recommendation against Shingles - Concept note

2022 ∙ Haute Autorité de Santé

Vaccination strategy against Covid-19: role of the bivalent Spikevax Original / Omicron BA.4/BA.5 vaccine (mRNA-1273.222)